Sveriges mest populära poddar

Ep. 101 - Of Biotech Bears, Pazdur & PDUFA

29 min•8 februari 2022

Weathering the bear market. Oncology chief’s change in thinking on PD-1 therapies. Plus BioCentury’s 2021 innovative start-ups. This week’s podcast is sponsored by ICON.

Reach us by sending a text

Fler avsnitt av BioCentury This Week

Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision

30 mars•29 min

Ep. 356 - Arrowhead’s arc. Plus: AI in biotech venture, Synnovation, MFN

24 mars•34 min

Ep. 355 - Capital market mood, Xenon data, Friedreich ataxia pipeline

17 mars•25 min

Ep. 354 - East-West Summit Takeaways

14 mars•26 min

Ep. 353 - Prasad Departure and Future of Fibrosis Therapies

9 mars•37 min

Ep. 352 - A Multipolar Biopharma World; Rare Disease Spotlight

3 mars•35 min

Ep. 351 - Gilead's Arcellx Buy. Plus: ctDNA as Surrogate Endpoint

24 feb.•35 min

Ep. 350 - Oral SERD Spotlight. Plus: Setbacks at FDA

17 feb.•26 min

Ep. 349 - Start-up Spotlight, Compounding Wegovy & Neuropysch

10 feb.•34 min

Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules

3 feb.•31 min

BioCentury This Week med BioCentury finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.